UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

PloS one, 2018-05, Vol.13 (5), p.e0196791-e0196791

2018

Volltextzugriff (PDF)

Quinolinone-based agonists of S1P1: Use of a N-scan SAR strategy to optimize in vitro and in vivo activity

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.527-531

2012

Volltextzugriff (PDF)

Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups

Bioorganic & medicinal chemistry letters, 2012-02, Vol.22 (4), p.1779-1783

2012

Volltextzugriff (PDF)

Synthesis of Aromatic Heterocycles via Palladium-Catalyzed Annulation of Internal Alkynes

Journal of organic chemistry, 1995-06, Vol.60 (11), p.3270-3271

1995

Volltextzugriff (PDF)

Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold

Journal of medicinal chemistry, 2008-10, Vol.51 (20), p.6271-6279

2008

Volltextzugriff (PDF)

Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core

ACS medicinal chemistry letters, 2012-01, Vol.3 (1), p.74-78

2012

Volltextzugriff (PDF)

The optimization of aminooxadiazoles as orally active inhibitors of Cdc7

Bioorganic & medicinal chemistry letters, 2013-12, Vol.23 (23), p.6396-6400

2013

Volltextzugriff (PDF)

4-Methoxy- N -[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P 1

ACS medicinal chemistry letters, 2011-10, Vol.2 (10), p.752-757

2011

Volltextzugriff (PDF)

First X-ray Cocrystal Structure of a Bacterial FabH Condensing Enzyme and a Small Molecule Inhibitor Achieved Using Rational Design and Homology Modeling

Journal of medicinal chemistry, 2003-01, Vol.46 (1), p.5-8

2003

Volltextzugriff (PDF)

Purification of N-acetylgalactosamine-modified-oligonucleotides using orthogonal anion-exchange and mixed-mode chromatography approaches

Journal of Chromatography A, 2022-01, Vol.1661, p.462679, Article 462679

2022

Volltextzugriff (PDF)

4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1

ACS medicinal chemistry letters, 2011-10, Vol.2 (10), p.752-757

2011

Volltextzugriff (PDF)

Purification of guanine-quadruplex using monolithic stationary phase under ion-exchange conditions

Journal of Chromatography A, 2020-12, Vol.1634, p.461633, Article 461633

2020

Volltextzugriff (PDF)

Plasma and Liver Protein Binding of N -Acetylgalactosamine-Conjugated Small Interfering RNA

Drug metabolism and disposition, 2019-10, Vol.47 (10), p.1174-1182

2019

Volltextzugriff (PDF)

Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx‑V Peptide 5‑Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Journal of medicinal chemistry, 2018-11, Vol.61 (21), p.9500-9512

2018

Volltextzugriff (PDF)

Pharmacological characterization of potent and selective Na.sub.V1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

PloS one, 2018-05, Vol.13 (5), p.e0196791

2018

Volltextzugriff (PDF)

Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species

Drug metabolism and disposition, 2019-10, Vol.47 (10), p.1111-1121

2019

Volltextzugriff (PDF)

Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease

Nucleic acid therapeutics, 2021-10, Vol.31 (5), p.324

2021

Volltextzugriff (PDF)

Discovery of Tarantula Venom-Derived Na V 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Journal of medicinal chemistry, 2018-11, Vol.61 (21), p.9500-9512

2018

Volltextzugriff (PDF)

Discovery of Tarantula Venom-Derived NaV 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Journal of medicinal chemistry, 2018-10, Vol.61 (21)

2018

Volltextzugriff (PDF)

(E)-3-[6-[[(2,6-Dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2- propenoic Acid: A High-Affinity Leukotriene B4 Receptor Antagonist with Oral Antiinflammatory Activity

Journal of medicinal chemistry, 1996-09, Vol.39 (19), p.3837-3841

1996

Volltextzugriff (PDF)

Abstract 711: Small molecule compounds that target cell division cycle 7 (Cdc7) kinase inhibit cell proliferation and tumor growth

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.711-711

2013

Volltextzugriff (PDF)

3-Amino-7-phthalazinylbenzoisoxazoles as a Novel Class of Potent, Selective, and Orally Available Inhibitors of p38α Mitogen-Activated Protein Kinase

Journal of medicinal chemistry, 2008-10, Vol.51 (20), p.6280-6292

2008

Volltextzugriff (PDF)

Optimization of a Potent, Orally Active S1P 1 Agonist Containing a Quinolinone Core

ACS medicinal chemistry letters, 2012-01, Vol.3 (1), p.74-78

2012

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

Quinolinone-based agonists of S1P1: Use of a N-scan SAR strategy to optimize in vitro and in vivo activity

Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups

Synthesis of Aromatic Heterocycles via Palladium-Catalyzed Annulation of Internal Alkynes

Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold

Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core

The optimization of aminooxadiazoles as orally active inhibitors of Cdc7

4-Methoxy- N -[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P 1

First X-ray Cocrystal Structure of a Bacterial FabH Condensing Enzyme and a Small Molecule Inhibitor Achieved Using Rational Design and Homology Modeling

Purification of N-acetylgalactosamine-modified-oligonucleotides using orthogonal anion-exchange and mixed-mode chromatography approaches

4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1

Purification of guanine-quadruplex using monolithic stationary phase under ion-exchange conditions

Plasma and Liver Protein Binding of N -Acetylgalactosamine-Conjugated Small Interfering RNA

Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx‑V Peptide 5‑Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Pharmacological characterization of potent and selective Na.sub.V1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species

Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease

Discovery of Tarantula Venom-Derived Na V 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Discovery of Tarantula Venom-Derived NaV 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Engineering NaV1.7 Inhibitory JzTx‑V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics

Engineering Na V 1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics

(E)-3-[6-[[(2,6-Dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2- propenoic Acid: A High-Affinity Leukotriene B4 Receptor Antagonist with Oral Antiinflammatory Activity

Abstract 711: Small molecule compounds that target cell division cycle 7 (Cdc7) kinase inhibit cell proliferation and tumor growth

3-Amino-7-phthalazinylbenzoisoxazoles as a Novel Class of Potent, Selective, and Orally Available Inhibitors of p38α Mitogen-Activated Protein Kinase

Optimization of a Potent, Orally Active S1P 1 Agonist Containing a Quinolinone Core

Suchergebnisse filtern